Diane E. Paul, MS, RN, Joins National Comprehensive Cancer Network as Vice President, Clinical Trials Network

Business Wire, June 20, 2005

JENKINTOWN, Pa. -- William T. McGivney, Ph.D., CEO of the National Comprehensive Cancer Network (NCCN), announces that Diane E. Paul, MS, RN, has joined NCCN as Vice President, Clinical Trials Network. In this role, Paul will be responsible for developing a centralized, standardized infrastructure for the conduct of clinical trials among NCCN's 19 member institutions.

"This network will be of interest to pharmaceutical/biotechnology companies for the conduct of their trials. And, it is our hope that collaboration will bring promising and effective new treatments to cancer patients," said McGivney.

Paul launched the NCCN Clinical Trials Network during her original tenure at NCCN from 1999 to 2003. Before rejoining NCCN, Paul served as Executive Director of the Cancer Institute of New Jersey Oncology Group and Director of the Cancer Institute of New Jersey Network at the University of Medicine and Dentistry of New Jersey in New Brunswick, New Jersey. She speaks often on such topics as cancer screening and prevention and has published articles in clinical publications including Cancer Investigation, Cancer Practice, and Oncology Nursing Forum.

For her work with the Cancer Hope Network, Paul received an "Unsung Heroine Award" in 1988 - an honor sponsored by the Women's Network of New Jersey and presented by Senator Bill Bradley. She also received the Information Service Partnership Award from the National Cancer Institute in 1996. She is a recipient of Coping magazine's Hero Award and Mirabella's "1000 Points of Light" Award.

Paul completed her master's degree in psychiatric/mental health nursing at Rutgers University and her undergraduate degree in nursing science at the College of Saint Elizabeth in Convent Station, New Jersey. She is a member of the Association of Cancer Executives, the American Society of Clinical Oncology and the Oncology Nursing Society.

For more information about NCCN, contact Susan Sommerville at 215-690-0254.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), an alliance of 19 of the world's leading cancer centers, is dedicated to improving the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN member institutions, NCCN develops resources that present valuable information to the numerous stakeholders throughout the health care delivery system. As the arbiter of high-quality cancer care, NCCN emphasizes the importance of and promotes continuous quality improvement, creating and publishing clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. NCCN programs include: Clinical Practice Guidelines in Oncology(TM), the NCCN Drugs & Biologics Compendium(TM), Treatment Guidelines for Patients, the Journal of the National Comprehensive Cancer Network (JNCCN), Cancer Resource Lines for Leukemia and Multiple Myeloma, educational conferences and symposia for clinicians, the Oncology Outcomes Project, the NCCN Clinical Trials Network, NCCN Cancer Case Manager(TM), and collaborations with managed care organizations.

The NCCN member institutions are:

--City of Hope Cancer Center

--Dana-Farber/Partners CancerCare

--Duke Comprehensive Cancer Center

--Fox Chase Cancer Center

--Huntsman Cancer Institute at the University of Utah

--Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance

--Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University

--The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

--Robert H. Lurie Comprehensive Cancer Center of Northwestern University

--Memorial Sloan-Kettering Cancer Center

--H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida

--Roswell Park Cancer Institute

--St. Jude Children's Research Hospital / University of Tennessee Cancer Institute

--Stanford Hospital & Clinics

--University of Alabama at Birmingham Comprehensive Cancer Center

--UCSF Comprehensive Cancer Center

--University of Michigan Comprehensive Cancer Center

--UNMC Eppley Cancer Center at The Nebraska Medical Center

--The University of Texas M. D. Anderson Cancer Center